All cases (n = 304) | Attempted lesion excision (n = 235) | Only diagnostic lesion sampling (n = 69) | P-value | |
---|---|---|---|---|
Was any IFU done by patient? | 0.678 | |||
Yes | 256 (84%) | 199 (85%) | 57 (83%) | |
No | 48 (16%) | 36 (15%) | 12 (17%) | |
Was IFU imaging performed? | <0.001 | |||
Yes | 189 (62%) | 170 (72%) | 19 (28%) | |
No | 51 (17%) | 38 (16%) | 13 (19%) | |
Instead had subsequent excisional breast procedure performed | 64 (21%) | 27 (12%) | 37 (54%) | |
Median time to IFU imaging (months) for those (n = 189) undergoing IFU imaging | 6 (3–16) | 6 (3–16) | 6 (3–8) | 0.110 |
Was IFU ultrasound performed? | <0.001 | |||
Yes | 188 (62%) | 170 (72%) | 18 (26%) | |
No | 52 (17%) | 38 (16%) | 14 (20%) | |
Instead had subsequent excisional breast procedure performed | 64 (21%) | 27 (12%) | 37 (54%) | |
Was a residual ultrasound lesion visible for those undergoing IFU ultrasound (n = 188)? | <0.001 | |||
Yes | 34 (18%) | 19 (11%) | 15 (83%) | |
No | 154 (82%) | 151 (89%) | 3 (17%) | |
Was IFU mammogram performed? | <0.001 | |||
Yes | 179 (59%) | 162 (69%) | 17 (25%) | |
No | 61 (20%) | 46 (20%) | 15 (22%) | |
Instead had subsequent excisional breast procedure done | 64 (21%) | 27 (12%) | 37 (54%) | |
Was a residual mammographic lesion visible for those undergoing IFU mammogram (n = 179)? | 0.001 | |||
Yes | 11 (6%) | 6 (4%) | 5 (29%) | |
No | 168 (94%) | 156 (96%) | 12 (71%) | |
For those undergoing a pre-procedural mammogram (which demonstrated a mammographic lesion) and who had both an IFU ultrasound and an IFU mammogram, was a residual ultrasound lesion visible on IFU ultrasound (n = 110)? | <0.001 | |||
Yes | 21 (19%) | 14 (14%) | 7 (88%) | |
No | 89 (81%) | 88 (86%) | 1 (12%) | |
For those undergoing a pre-procedural mammogram (which demonstrated a mammographic lesion) and who had both an IFU ultrasound and an IFU mammogram, was a residual mammographic lesion visible on IFU mammogram (n = 110)? | 0.001 | |||
Yes | 9 (8%) | 5 (5%) | 4 (50%) | |
No | 101 (92%) | 97 (95%) | 4 (50%) | |
Median duration of IFU (months) for those (n = 256) undergoing IFU | 11 (1–37) | 9 (2–37) | 13 (1–30) | 0.146 |